Surgical Science Sweden AB (SUS) - Total Liabilities

Latest as of June 2026: Skr420.02 Million SEK ≈ $45.20 Million USD

Based on the latest financial reports, Surgical Science Sweden AB (SUS) has total liabilities worth Skr420.02 Million SEK (≈ $45.20 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SUS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Surgical Science Sweden AB - Total Liabilities Trend (2014–2025)

This chart illustrates how Surgical Science Sweden AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Surgical Science Sweden AB total assets.

Surgical Science Sweden AB Competitors by Total Liabilities

The table below lists competitors of Surgical Science Sweden AB ranked by their total liabilities.

Company Country Total Liabilities
Orient Cement Limited
NSE:ORIENTCEM
India Rs9.01 Billion
Xperi Corp
NYSE:XPER
USA $536.31 Million
Vivotek Inc
TW:3454
Taiwan NT$2.06 Billion
Com2uS Corporation
KQ:078340
Korea ₩501.87 Billion
What's Cooking Group NV/SA
BR:WHATS
Belgium €107.96 Million
LINAS AGRO GROUP EO 029
F:YG4
Germany €676.54 Million
Politeknik Metal Sanayi ve
IS:POLTK
Turkey TL30.41 Million
Chia Hsin Cement Corp
TW:1103
Taiwan NT$14.45 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Surgical Science Sweden AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SUS net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.24 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.09 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.08 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Surgical Science Sweden AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Surgical Science Sweden AB (2014–2025)

The table below shows the annual total liabilities of Surgical Science Sweden AB from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 Skr418.31 Million
≈ $45.02 Million
-35.75%
2024-12-31 Skr651.03 Million
≈ $70.06 Million
+82.13%
2023-12-31 Skr357.46 Million
≈ $38.47 Million
-13.47%
2022-12-31 Skr413.11 Million
≈ $44.46 Million
+5.10%
2021-12-31 Skr393.06 Million
≈ $42.30 Million
+769.14%
2020-12-31 Skr45.22 Million
≈ $4.87 Million
-17.08%
2019-12-31 Skr54.54 Million
≈ $5.87 Million
+168.97%
2018-12-31 Skr20.28 Million
≈ $2.18 Million
+51.32%
2017-12-31 Skr13.40 Million
≈ $1.44 Million
-67.56%
2016-12-31 Skr41.30 Million
≈ $4.44 Million
+17.66%
2015-12-31 Skr35.10 Million
≈ $3.78 Million
+200.86%
2014-12-31 Skr11.67 Million
≈ $1.26 Million
--

About Surgical Science Sweden AB

ST:SUS Sweden Health Information Services
Market Cap
$271.05 Million
Skr2.52 Billion SEK
Market Cap Rank
#15399 Global
#249 in Sweden
Share Price
Skr49.36
Change (1 day)
+1.15%
52-Week Range
Skr23.92 - Skr91.75
All Time High
Skr324.75
About

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquis… Read more